Meejeon Roh, Ph.D.
Affiliations: | 2001 | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Cell BiologyGoogle:
"Meejeon Roh"Parents
Sign in to add mentorJeffrey E. Kudlow | grad student | 2001 | UAB | |
(Studies of epidermal growth factor receptor and transforming growth factor alpha in the pituitary gland using transgenic mouse models.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Unno K, Roh M, Yoo YA, et al. (2017) Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids. Oncotarget. 8: 51264-51276 |
Unno K, Roh M, Yoo YA, et al. (2017) Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids. Oncotarget |
Yoo YA, Roh M, Naseem AF, et al. (2016) Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation. Nature Communications. 7: 12943 |
Park SH, Ozden O, Liu G, et al. (2016) SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor growth. Cancer Research |
van der Meer R, Song HY, Park SH, et al. (2014) RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3211-21 |
Abdulkadir S, Meer RV, Roh M. (2013) Abstract 5185: RNAi screen identifies a synthetic lethal interaction between Pim1 overexpression and Plk1 inhibition. Cancer Research. 73: 5185-5185 |
Anderson PD, McKissic SA, Logan M, et al. (2012) Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. The Journal of Clinical Investigation. 122: 1907-19 |
Roh M, van der Meer R, Abdulkadir SA. (2012) Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatment. Journal of Cellular Physiology. 227: 801-12 |
Anderson PD, McKissic SA, Logan M, et al. (2012) Abstract 2983: Nkx3.1 and c-Myc co-regulate shared target genes involved in prostate cancer Cancer Research. 72: 2983-2983 |
Wang J, Anderson PD, Luo W, et al. (2011) Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells. Oncogene. 31: 1794-803 |